Haldol (Haloperidol) - FDA Alerts

FDA Alerts related to Haldol (Haloperidol)

FDA ALERT [9/2007]:  This Alert highlights revisions to the labeling for haloperidol (marketed as Haldol, Haldol Decanoate and Haldol Lactate).  The updated labeling includes WARNINGS stating that Torsades de Pointes and QT prolongation have been observed in patients receiving haloperidol, especially when the drug is administered intravenously or in higher doses than recommended.  Haloperidol is not approved for intravenous use.